NCT00962091View on ClinicalTrials.gov

Study of MLN8237 in Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 25, 2009

Primary Completion Date

December 28, 2011

Study Completion Date

July 1, 2014

Conditions
Advanced Solid Tumors
Interventions
DRUG

Alisertib

Alisertib OS Alisertib PIC Alisertib PIC

Trial Locations (1)

90404

Premiere Oncology, A Medical Corporation, Santa Monica

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY